Shihua Shi Selected Research

Shihua Shi Research Topics

Disease

6	Pulmonary Edema 11/2023 - 07/2022
6	Lung Injury 07/2023 - 01/2021
5	Inflammation (Inflammations) 11/2023 - 02/2022
4	Hypoxia (Hypoxemia) 11/2023 - 08/2023
4	COVID-19 01/2023 - 01/2021
3	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2023 - 06/2022
3	Pneumonia (Pneumonitis) 06/2022 - 01/2021
2	Infections 01/2024 - 07/2018
1	Neoplasm Metastasis (Metastasis) 11/2023
1	Neoplasms (Cancer) 11/2023
1	Altitude Sickness (Mountain Sickness) 10/2023
1	Ischemic Stroke 09/2023
1	Stroke (Strokes) 09/2023
1	Atherosclerosis 09/2023
1	Heart Diseases (Heart Disease) 08/2023
1	Heart Failure 08/2023
1	Fatigue 08/2023
1	Heart Injuries 08/2023
1	Lung Diseases (Lung Disease) 07/2023
1	Edema (Dropsy) 12/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2022
1	Acute Coronary Syndrome 01/2022
1	Osteoporosis 01/2022
1	Angina Pectoris 11/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Intestinal Obstruction (Obstruction, Intestinal) 07/2018
1	Sepsis (Septicemia) 03/2017
1	Acute Kidney Injury (Acute Renal Failure) 03/2017

Drug/Important Bio-Agent (IBA)

5	InflammasomesIBA 01/2024 - 06/2022
4	Particulate MatterIBA 07/2023 - 07/2022
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2022
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2022
3	Therapeutic UsesIBA 01/2023 - 07/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2022 - 07/2022
3	astragaloside AIBA 11/2022 - 01/2021
2	notoginsenoside R1IBA 11/2023 - 10/2023
2	eleutheroside EIBA 11/2023 - 08/2023
2	CytokinesIBA 11/2023 - 06/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 12/2022
2	Triglycerides (Triacylglycerol)IBA 09/2023 - 11/2019
2	LDL CholesterolIBA 09/2023 - 11/2019
2	Interleukin-6 (Interleukin 6)IBA 09/2023 - 11/2022
2	Caspase 1 (ICE Protease)IBA 08/2023 - 06/2022
2	Silk FDA Link 11/2019 - 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 11/2023
1	Small Interfering RNA (siRNA)IBA 11/2023
1	NLR ProteinsIBA 11/2023
1	procyanidin trimer C1IBA 11/2023
1	CollagenIBA 11/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023
1	BerberineIBA 09/2023
1	oxidized low density lipoproteinIBA 09/2023
1	C-Reactive ProteinIBA 09/2023
1	Complement C3 (C3 Complement)IBA 09/2023
1	Cysteine (L-Cysteine)FDA Link 09/2023
1	Macrophage Migration-Inhibitory FactorsIBA 09/2023
1	Oxygen (Dioxygen)IBA 08/2023
1	NigericinIBA 08/2023
1	Hematoxylin (Haematoxylon)IBA 07/2023
1	ImmunosorbentsIBA 07/2023
1	rhodiolosideIBA 07/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2023
1	EnzymesIBA 07/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 05/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	rosavinIBA 01/2023
1	syringinIBA 12/2022
1	InterleukinsIBA 11/2022
1	peiminineIBA 07/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2022
1	Chloroquine (Aralen)FDA LinkGeneric 02/2022
1	SuspensionsIBA 02/2022
1	TOR Serine-Threonine KinasesIBA 02/2022
1	Shen-FuIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	von Willebrand FactorIBA 01/2022
1	AconitineIBA 01/2022
1	ProcalcitoninIBA 01/2022
1	SelectinsIBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	3-methyladenineIBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	CholesterolIBA 11/2019
1	LipidsIBA 11/2019
1	HDL CholesterolIBA 11/2019
1	TeaIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2018
1	LaxativesIBA 07/2018
1	XuebijingIBA 03/2017

Therapy/Procedure

4	Therapeutics 09/2023 - 07/2018
3	Drug Therapy (Chemotherapy) 11/2023 - 01/2021
1	Stents 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Immunotherapy 01/2021
1	Enema (Enemas) 07/2018
1	Moxibustion 07/2018
1	Decompression 07/2018
1	Parenteral Nutrition 07/2018
1	Duration of Therapy 07/2018